College of Pharmacy, Chung-Ang University, 221 Heuksuk-dong, Dongjak-gu, Seoul 156-756, Republic of Korea.
Int J Pharm. 2013 Aug 16;452(1-2):311-20. doi: 10.1016/j.ijpharm.2013.05.023. Epub 2013 May 20.
Surface-modified solid lipid nanoparticles (SLNs) containing retinyl palmitate (Rpal) were prepared by the hot-melt method using Gelucire 50/13(®) and Precirol ATO5(®). Dicetyl phosphate (DCP) was added to negatively charge the surfaces of the SLNs and thereby enhance the skin distribution properties of Rpal. In vitro skin permeation and in vivo anti-aging studies were performed using SLNs dispersed in a hydrogel. The SLNs were under 100 nm in size with an even polydispersity index (PDI), and the high absolute zeta-potential value was sufficient to maintain the colloidal stability of the SLNs. DCP-modified negative SLNs (DCPmod-SLNs) enhanced the skin distribution of Rpal 4.8-fold and delivered Rpal to a greater depth than did neutral SLNs. The in vivo anti-wrinkle effect of the DCPmod-SLN formulation was Rpal dose-dependent. However, the anti-wrinkle effects of the DCPmod-SLN formulations were significantly different from that of the negative control and effectively prevented the reduction of elastin and superoxide dismutase by UV irradiation. In conclusion, the DCPmod-SLN system presented is a good candidate for topical Rpal delivery.
载有视黄醇棕榈酸酯(Rpal)的表面修饰固体脂质纳米粒(SLNs)通过热熔法使用 Gelucire 50/13(®)和 Precirol ATO5(®)制备。二硬脂酸磷酸酯(DCP)被添加到 SLNs 的表面以使其带负电荷,从而增强 Rpal 的皮肤分布特性。使用分散在水凝胶中的 SLNs 进行了体外皮肤渗透和体内抗衰老研究。SLNs 的粒径小于 100nm,具有均匀的多分散指数(PDI),并且高绝对值的 Zeta 电位值足以维持 SLNs 的胶体稳定性。DCP 修饰的负 SLNs(DCPmod-SLNs)使 Rpal 的皮肤分布增加了 4.8 倍,并将 Rpal 递送至比中性 SLNs 更深的深度。DCPmod-SLN 制剂的体内抗皱效果与 Rpal 剂量呈依赖性。然而,DCPmod-SLN 制剂的抗皱效果与阴性对照有显著差异,并能有效防止 UV 照射引起的弹性蛋白和超氧化物歧化酶减少。总之,所提出的 DCPmod-SLN 系统是一种用于局部 Rpal 递送的良好候选物。